Evidence map›Paper›PMID 28632040›Full record

ReviewJournal of toxicology and environmental health. Part B, Critical reviews2017

Engineered nanomaterial-induced lysosomal membrane permeabilization and anti-cathepsin agents.

Melisa Bunderson-Schelvan, Andrij Holian, Raymond F Hamilton

Abstract readReview
In one paragraph

Review in Journal of toxicology and environmental health. Part B, Critical reviews, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Crumpling of silver nanowires by endolysosomes strongly reduces toxicity.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Melisa Bunderson-Schelvana Center for Environmental Health Sciences , University of Montana , Missoula , MT , USA.
Andrij Holiana Center for Environmental Health Sciences , University of Montana , Missoula , MT , USA.
Raymond F Hamiltona Center for Environmental Health Sciences , University of Montana , Missoula , MT , USA.
Center for Environmental Health · USUniversity of Montana · US

Funding

Dietary DHA attenuation of nanoparticle inflammationR01ES023209 · NIEHS · UNIVERSITY OF MONTANA · PI HOLIAN, ANDRIJ · 2014 to 2018
$2.8M
NIEHS NIH HHS R01 ES023209
6 · The paper itself

Abstract

Engineered nanomaterials (ENMs), or small anthropogenic particles approximately < 100 nm in size and of various shapes and compositions, are increasingly incorporated into commercial products and used for industrial and medical purposes. There is an exposure risk to both the population at large and individuals in the workplace with inhalation exposures to ENMs being a primary concern. Further, there is increasing evidence to suggest that certain ENMs may represent a significant health risk, and many of these ENMs exhibit distinct similarities with other particles and fibers that are known to induce adverse health effects, such as asbestos, silica, and particulate matter (PM). Evidence regarding the importance of lysosomal membrane permeabilization (LMP) and release of cathepsins in ENM toxicity has been accumulating. The aim of this review was to describe our current understanding of the mechanisms leading to ENM-associated pathologies, including LMP and the role of cathepsins with a focus on inflammation. In addition, anti-cathepsin agents, some of which have been tested in clinical trials and may prove useful for ameliorating the harmful effects of ENM exposure, are examined.

Indexed as

AnimalsCathepsinsEnvironmental ExposureHumansInflammationInhalation ExposureLysosomesNanostructuresOccupational ExposureParticle SizeCathepsins

Identifiers

PMID28632040
PMCPMC6127079
OpenAlexW2642290705

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.